Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. Total Liabilities 2023–2025
Entrada Therapeutics Inc. annual/quarterly total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Entrada Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 71.2M, a 27.04% decrease year-over-year.
- Entrada Therapeutics Inc. total liabilities for 2025 were 71.2M, a 27.04% decrease from 2024.
- Entrada Therapeutics Inc. total liabilities for 2024 were 97.6M, a 56.95% decrease from 2023.
- Entrada Therapeutics Inc. total liabilities for 2023 were 226.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Entrada Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $71 |
| 2024 | $98 |
| 2023 | $227 |
| Entrada Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $71 |
| 2024-12-31 | $98 |
| 2023-12-31 | $227 |
Entrada Therapeutics Inc. Total Liabilities — FAQ
Entrada Therapeutics Inc. (TRDA) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRDA's total liabilities history?
The chart and table above show Entrada Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.